Stock listing
Vor Biopharma Inc.
Selected listing: VOR · NASDAQ · USD · US
Vor Biopharma Inc. (NASDAQ:VOR), Health Technology. Latest release Oct 5, 2026: Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
- Ticker
- NASDAQ:VOR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Vor Biopharma Inc.
Vor Biopharma Inc. is a public company traded under the ticker VOR in the American market. Vor Biopharma focuses on developing innovative therapies to treat cancer through its proprietary technology.
Latest news from Vor Biopharma Inc.
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 5, 2026
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 4, 2026
Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis
September 8, 2026
Vor Bio To Participate in Upcoming September Conferences
September 1, 2026
Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026